Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers

Tsuguhisa Nakayama1,2, Ivan T Lee1,3,4, Sizun Jiang4,5

  • 1Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, 801 Welch Road, Stanford, CA, USA.

Cell Reports. Medicine
|October 4, 2021
PubMed

Insights

This study reveals SARS-CoV-2 tropism in head and neck tissues, with higher infection in smokers linked to lower interferon levels. Understanding viral entry factors like ACE2 and TMPRSS2 is key to reducing COVID-19 spread and severity.

Area of Science:

  • Virology
  • Respiratory Medicine
  • Immunology

Background:

  • Understanding SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) viral tropism is crucial for controlling COVID-19 (coronavirus disease 2019) transmission and severity.
  • Limited knowledge exists regarding SARS-CoV-2 infection and replication selectivity in human head, neck, and proximal airway tissues.
  • Key viral entry factors, angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), play a role in SARS-CoV-2 infection.

Purpose of the Study:

  • To investigate SARS-CoV-2 tropism across various mucosal tissues in the human head and neck region and proximal respiratory tract.
  • To identify variations in ACE2 and TMPRSS2 expression in these tissues and their correlation with viral infection.
  • To explore the association between smoking and SARS-CoV-2 infection susceptibility and severity in the proximal airway.

Main Methods:

  • Translational research study examining mucosal tissue samples from the human head and neck and proximal respiratory tract.
  • Analysis of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) expression levels.
  • Detection and quantification of SARS-CoV-2 infection in tissue samples.
  • Assessment of interferon (IFN)-β1 levels in smokers and non-smokers.

Main Results:

  • Significant variability in ACE2 and TMPRSS2 expression was observed among proximal airway mucosal tissues.
  • SARS-CoV-2 infection was detected in all examined head and neck tissues, with pronounced tropism for the nasal cavity and tracheal mucosa.
  • A positive association was found between smoking and increased SARS-CoV-2 viral infection in the proximal airway.
  • Lower interferon (IFN)-β1 levels were noted in smokers compared to non-smokers, potentially explaining increased susceptibility to severe COVID-19.

Conclusions:

  • The study identifies specific tropism of SARS-CoV-2 within the human head and neck and proximal airway, highlighting the nasal cavity and trachea.
  • Variations in ACE2 and TMPRSS2 expression contribute to differential viral susceptibility.
  • Smoking is associated with higher SARS-CoV-2 infection and potentially more severe COVID-19 outcomes, possibly due to altered interferon responses.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
696
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
421
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K